Strides Considers Sputnik Light Production

US Filing For GLP Analog In Dec

Strides will consider making RDIF’s Sputnik Light vaccine after filling orders for Sputnik V, which it expects to launch in October. The COVID-19 portfolio is being expanded and the Indian company is set to make a Para IV filing for a diabetes product in December, CEO R Ananthanarayanan tells Scrip.

Business Strategy Concept
Strides Formulating Its COVID-19 Business Strategy • Source: Alamy

More from Business

More from Scrip